Form 4: Carlyle Group Sells Additional Shares of QuidelOrtho Corp (QDEL) Under 10b5-1 Plan

Carlyle Group continues to reduce its stake in QuidelOrtho Corp, selling shares under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Carlyle Group, a major shareholder of QuidelOrtho Corp (QDEL), has sold shares of common stock on August 5th and 6th, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• On August 5th, a total of 118,172 shares were sold at weighted average prices ranging from $38.97 to $41.1703.
• On August 6th, a total of 86,972 shares were sold at weighted average prices ranging from $39.45 to $40.97.
• Following these transactions, Carlyle Group's indirect beneficial ownership stands at 8,519,202 shares.
• The shares are held of record by Carlyle Partners VI Cayman Holdings, L.P.
• Carlyle Group Inc. and several related entities may be deemed to share beneficial ownership but disclaim it.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document simply reports transactions under a pre-existing plan. There is no indication of positive or negative outlook for the company.

Risks

• Continued sales by Carlyle Group could exert downward pressure on QuidelOrtho's stock price.

Future Outlook

The document does not provide specific forward-looking statements for QuidelOrtho, but indicates continued sales under the 10b5-1 plan.

Industry Context

Share sales by major holders are common and can reflect portfolio adjustments or strategic decisions by the selling entity. The impact on QuidelOrtho's stock will depend on market perception and overall investor sentiment.

Stakeholder Impact

• Shareholders may experience slight downward pressure on the stock price due to the sale of shares by a major holder.
• The impact on other stakeholders is likely minimal.

Key Dates